Cancer detections systems maker VuCOMP announced this week that it won FDA approval for new computer-aided detection software, launching version 3.1 of its M-Vu CAD for mammography.

The FDA nod allows VuCOMP to upgrade the M-Vu CAD system, which uses advanced software to help detect suspect areas in mammograms. The company provides the upgrades at no additional cost to customers, according to a press release.

The M-Vu CAD technology works with a variety of imaging technologies, including systems made by CareStream Health, GE Healthcare (NYSE:GE), Hologic (NSDQ:HOLX), Siemens (NYSE:SI), Philips (NYSE:PHG) and others. The company offers no-charge 30-day trials for its M-Vu CAD system, according to its website.

"We are committed to the continuous improvement of our product line, and each new release of M-Vu CAD offers advances that provide substantial value to the system and our customers," VuCOMP president & CTO Jim Pike said in prepared remarks. "These latest updates are no exception."

VuCOMP is having a strong year, announcing earlier this month that the company is expanding its sales force to "take advantage of growing market opportunity for its automated M-Vu Breast Density and M-Vu CAD products." The device maker also plans to expand its reach in Europe and Asia.